What is Global Viscosupplements Market?
The Global Viscosupplements Market is a fascinating and complex sector of the healthcare industry. Viscosupplements are injections that are used to treat osteoarthritis pain, particularly in the knee. These injections are made of hyaluronic acid, a naturally occurring substance in the body that helps to lubricate joints and cushion them from impact. The global market for these treatments is vast and varied, with a wide range of products available to suit different needs and budgets. In 2023, the market was valued at a staggering US$ 1822.1 million, and it's only expected to grow from there. With advancements in medical technology and an increasing global population, the demand for effective, non-surgical treatments for osteoarthritis is higher than ever.
Single Injection, Three Injection, Five Injection in the Global Viscosupplements Market:
The Global Viscosupplements Market is divided into three main categories based on the number of injections required: single injection, three injections, and five injections. Single injection viscosupplements are a convenient option for patients, as they require only one visit to the doctor. However, they may not provide as long-lasting relief as other options. Three injection viscosupplements are administered over the course of three weeks, providing more sustained relief. Five injection viscosupplements, while requiring the most visits to the doctor, offer the longest-lasting relief from osteoarthritis pain. Each type of viscosupplement has its own advantages and disadvantages, and the best choice will depend on the individual patient's needs and lifestyle.
Hospital Pharmacies, Retail Pharmacies in the Global Viscosupplements Market:
Viscosupplements are commonly used in a variety of settings, including hospital pharmacies and retail pharmacies. Hospital pharmacies often administer viscosupplements to patients who are undergoing other treatments for osteoarthritis, such as physical therapy or surgery. Retail pharmacies, on the other hand, often provide viscosupplements to patients who are managing their osteoarthritis at home. Both types of pharmacies play a crucial role in making these treatments accessible to the people who need them.
Global Viscosupplements Market Outlook:
To put the Global Viscosupplements Market into perspective, in 2023, it was valued at a substantial US$ 1822.1 million. Looking ahead, it's projected to reach an impressive US$ 2329.4 million by 2030. This represents a compound annual growth rate (CAGR) of 3.6% during the forecast period from 2024 to 2030. This steady growth is a testament to the increasing demand for non-surgical, effective treatments for osteoarthritis. As the global population ages and more people seek relief from this common condition, the market for viscosupplements is expected to continue its upward trajectory.
| Report Metric | Details |
| Report Name | Viscosupplements Market |
| Accounted market size in 2023 | US$ 1822.1 million |
| Forecasted market size in 2030 | US$ 2329.4 million |
| CAGR | 3.6% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda, Haohai Biological, Shanghai Jingfeng |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
